Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts

被引:25
作者
Espejo, M
Cutillas, B
Ventura, F
Ambrosio, S
机构
[1] Univ Barcelona, Unitat Bioquim, Dept Ciencies Fisiol 2, E-08907 Lhospitalet De Llobregat, Spain
[2] Univ Barcelona, Escola Infermia, E-08907 Lhospitalet De Llobregat, Spain
关键词
bone morphogenetic protein-2; foetal mesencephalic cells; neuronal grafts; dopamine; tyrosine hydroxylase; Parkinson's disease;
D O I
10.1016/S0304-3940(99)00708-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The transplantation of foetal mesencephalic cells (FMC) into the brain striatal system is an emerging treatment for Parkinson's disease, despite of the relatively poor survival of implanted cells. The ability of neurotrophic factors to regulate neurone survival and differentiation suggests they could be used to enhance the success of cerebral grafts. We analyzed the effect of pre-treatment of FMC suspensions with bone morphogenetic protein-2 (BMP-2) (50 ng/ml) prior to grafting into the striatum of 6-hydroxydopamine lesioned rats. The viability of a FMC suspension was enhanced in vitro by BMP-2. Four weeks after transplantation, the number of dopaminergic neurones was higher and their morphology more developed in grafts pre-treated with BMP-2, compared with non-pre-treated grafts and rats showed a significant reduction in the turning behaviour test. Thus, the pre-treatment of FMCs with BMP-2 should be considered, together with other neurotrophic factors, as a procedure for transplantational treatment of Parkinson's disease. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 23 条
  • [1] DEVELOPMENT OF INTRACEREBRAL DOPAMINERGIC GRAFTS - A COMBINED IMMUNOHISTOCHEMICAL AND AUTORADIOGRAPHIC STUDY OF ITS TIME COURSE AND ENVIRONMENTAL-INFLUENCES
    ABROUS, N
    GUY, J
    VIGNY, A
    CALAS, A
    LEMOAL, M
    HERMAN, JP
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 273 (01) : 26 - 41
  • [2] The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum
    Barker, RA
    Dunnett, SB
    Faissner, A
    Fawcett, JW
    [J]. EXPERIMENTAL NEUROLOGY, 1996, 141 (01) : 79 - 93
  • [3] Brundin P., 1994, FUNCTIONAL NEURAL TR, P9
  • [4] The effect of prior in vitro exposure of donor cells to trophic factors in neurotransplantation
    Chen, XL
    Roisen, FJ
    Gupta, M
    [J]. EXPERIMENTAL NEUROLOGY, 1996, 138 (01) : 64 - 72
  • [5] Dunnett S.B., 1992, NEURAL TRANSPLANTATI
  • [6] Engele J, 1998, J NEUROSCI RES, V51, P508, DOI 10.1002/(SICI)1097-4547(19980215)51:4<508::AID-JNR10>3.3.CO
  • [7] 2-V
  • [8] Engele J, 1998, J NEUROSCI RES, V53, P405, DOI 10.1002/(SICI)1097-4547(19980815)53:4<405::AID-JNR2>3.3.CO
  • [9] 2-V
  • [10] DOPAMINERGIC NEURAL GRAFTS AFTER 15 YEARS - RESULTS AND PERSPECTIVES
    HERMAN, JP
    ABROUS, ND
    [J]. PROGRESS IN NEUROBIOLOGY, 1994, 44 (01) : 1 - 35